Search results for: 'alcohol consumption AND workplace AND prevention'
- Did you mean
- alcohol consumption ad workplace ad prevention
- alcohol consumption ad workplace and prevention
- Related search terms
- alcohol use AND workplace AND prevention
- alcohol consumption AND workplace
- AND (SELECT (CASE WHEN (3989=1399) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,3989) END) FROM DUAL) IS NULL
- AND (SELECT (CASE WHEN (4327=4327) THEN NULL ELSE CTXSYS.DRITHSX.SN(1,4327) END) FROM DUAL) IS NULL
- AND (SELECT 1827 FROM (SELECT(SLEEP(20)))zydf)
-
09 Mar 2015  |  Europe  |  Market Research
Western and Eastern European Custom Procedure Trays and Packs (CPTP) Market
Ripe Opportunities Exist Within the Growing Landscape
The Western and Eastern European Custom Procedure Trays and Packs (CPTP) market is growing rapidly. CPTPs offer off-the-shelf convenience for hospitals, reduce costs, and lead to more-efficient operating rooms with faster turnaround times. The enforcement of stricter infection control measures has also greatly aided the adoption of CPTPs, as clinic...
$3,950.00
Special Price $2,962.50 save 25 %
-
30 Mar 2019  |  North America  |  Technology Research
Breakthroughs in Non-Alcoholic Steatohepatitis Management
Multiple Investigational New Drugs with high potential for better treatment outcomes progressing through critical stages of clinical development
Non-Alcoholic Steatohepatitis or NASH is a liver disorder that is characterized by the build-up of fat in liver in addition to inflammation and liver cell damage eventually progressing to cirrhosis. Currently lifestyle interventions are suggested for the treatment of NASH with no drugs having been approved for the condition. Multiple drugs are at ...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Dec 2022  |  Global  |  Technology Research
Advances and Growth Opportunities in RNA Vaccines
Technology Innovations and Investments Bolster Next-generation Prophylactic and Therapeutic RNA Vaccines
RNA therapeutics and vaccines have been around for a long time, but the COVID-19 pandemic enabled their mass-market commercialization. Industry players saw mRNA vaccines developed for COVID-19 as effective for reducing the impact of the SARS-CoV-2 virus in populations. Moderna emerged as the first player to develop and commercialize an mRNA vaccine...
$4,950.00
Special Price $3,712.50 save 25 %
-
05 Jun 2018  |  Global  |  Market Research
Anti-Aging Therapies and Services Market—Trends and Growth Opportunities, Forecast to 2022
Focus on Integrative Solutions Combining Dietary Supplements and Aesthetic Solutions with Clinical Therapeutics as the Market Moves Toward a ‘Prevent-Manage-Repair’ Continuum
The rapidly aging global population is placing immense pressure on healthcare systems across countries and regions. The improvement in life expectancy levels has created a large cohort of aged patients who suffer from one or more chronic diseases. Traditionally, the approach towards the management of this issue has been on ‘repair’, i.e., treatment...
$4,950.00
Special Price $3,712.50 save 25 %
-
09 Jan 2014  |  Global  |  Market Research
Merger and Acquisition (M&A) Trends in the Global Pharmaceutical and Biotechnology Industry
Increasing Volume and Decreasing Value
This study investigates the global stem cell market for the period 2013 to 2018. The geographic regions covered in the study are the North America, Europe and APAC, followed by a detailed Asia Pacific Region Analysis, which covers countries such as India, Australia, Thailand, Singapore, South Korea, Malaysia and Japan. The stem cell market is cover...
$4,950.00
Special Price $3,712.50 save 25 %
-
14 Jun 2024  |  Global  |  Market Research
Growth Opportunities in Global Diabetes and Obesity Therapeutics, 2024 2028
GLP-1 RA Drug Class, Combination Therapies, and Digital Convergence for Affordable Disease Management Drive Growth
Globally, diagnosis of metabolic diseases such as type 2 diabetes and obesity have increased. Since the COVID-19 pandemic, the global prevalence of obesity has worsened. Obesity is considered a main precursor of diabetes and contributes an estimated 80% to 85% toward the risk of type 2 diabetes. As a result, the financial burden associated with hea...
$4,950.00
Special Price $3,712.50 save 25 %
-
24 Nov 2021  |  Global  |  Technology Research
Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies
Need for Scalable, Reproducible, and Cost-Effective Manufacturing Processes Driving Growth Opportunities
The Frost & Sullivan research service discusses the cell and gene therapy (CGT) market and highlights some key roadblocks in viral vector manufacturing. While many CGT candidates exist in the pipeline, there is a huge capacity deficit that the industry is collaboratively trying to address. Scalability, costs, reproducibility, and overall process ef...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Jul 2017  |  North America  |  Market Research
US Oncology Diagnostics Market, Forecast to 2021
Manufacturers Increase Assay Development Focus Toward Screening, Prevention, and Therapy Selection
Personalized medicine continues to be a driver of new diagnostics to characterize the properties of an individual’s cancer. As a result, there is an increased focus on the development of non-invasive liquid biopsy companion diagnostic tests that would aid in choosing the best treatment for an individual. Liquid biopsy has triggered market consolida...
$4,950.00
Special Price $3,712.50 save 25 %
-
28 Mar 2019  |  Asia Pacific  |  Market Research
Malaysian Clinical Laboratories Market, Forecast to 2025
Shift toward Preventive Healthcare is Driving Market Growth
The market for healthcare services in Malaysia is less developed, with many clinical testing services being unavailable outside of cities. Unsubstantiated disease and unconfirmed mortality diagnoses are common in the country despite universal care, significant mixed investment in the local healthcare system, and health expenditure favourable to oth...
$1,500.00
Special Price $1,125.00 save 25 %
-
23 Aug 2019  |  South Asia, Middle East & North Africa  |  Market Outlook
Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020
Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020
In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transpire ...
$4,950.00
Special Price $3,712.50 save 25 %